External beam radiotherapy is associated with a 10% survival advantage in women with deeply myoinvasive, high-grade endometrial cancer only, but women at lower risk of recurrence do not benefit.

It is well recognized that, in many cases, endometrial carcinoma is a well differentiated ... definite evidence of secretory activity and a high incidence of squamous metaplasia, suggesting ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

The Food and Drug Administration (FDA) previously granted the combination regular approval for patients with advanced endometrial carcinoma that is not microsatellite instability-high (MSI-H ...

In a randomized trial of 427 patients with stage I or II endometrial cancer at high–intermediate risk of recurrence (defined as having two of the following: grade 3 histology, outer half ...